Get the Stockscreener App
9.39
0.00%
0.00
After Hours:
9.39
Avadel Pharmaceuticals Plc stock is traded at $9.39, with a volume of 1.36M.
It is up +0.00% in the last 24 hours and up +29.34% over the past month.
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. The group focused on transforming medicines to transform lives. It provides solutions to the development of medications that address the challenges patients face with current treatment options. The company is engaged in the development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy. It operates in one segment, the development and commercialization of pharmaceutical products, including controlled-release therapeutic products based on its proprietary polymer-based technology.
See More
Previous Close:
$9.39
Open:
$9.47
24h Volume:
1.36M
Relative Volume:
1.12
Market Cap:
$841.15M
Revenue:
$47.56M
Net Income/Loss:
$-156.83M
P/E Ratio:
-5.1311
EPS:
-1.83
Net Cash Flow:
$-127.98M
1W Performance:
+7.99%
1M Performance:
+29.34%
6M Performance:
-41.09%
1Y Performance:
-40.68%
1-Day Range:
$9.32
$9.67
1-Week Range:
$8.55
$9.98
52-Week Range:
$6.38
$17.51
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Name
Avadel Pharmaceuticals Plc
Sector
Phone
636-449-1830
Address
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Compare AVDL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
9.39 | 841.15M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
159.27 | 70.23B | 9.29B | 2.52B | 2.28B | 5.57 |
|
HLN
Haleon Plc Adr
|
10.74 | 48.23B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.36 | 48.22B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.93 | 18.57B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
301.42 | 13.29B | 2.76B | 1.11B | 898.10M | 22.77 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Jun-12-24 | Initiated | Rodman & Renshaw | Buy |
| Mar-05-24 | Reiterated | H.C. Wainwright | Buy |
| Mar-05-24 | Reiterated | Needham | Buy |
| Mar-05-24 | Reiterated | Oppenheimer | Outperform |
| Feb-06-24 | Initiated | UBS | Buy |
| Nov-30-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-10-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-28-22 | Resumed | Craig Hallum | Buy |
| May-26-22 | Downgrade | Stifel | Buy → Hold |
| Sep-23-21 | Initiated | Needham | Buy |
| Jul-31-20 | Initiated | Oppenheimer | Outperform |
| Jul-21-20 | Initiated | SVB Leerink | Outperform |
| Jun-30-20 | Initiated | H.C. Wainwright | Buy |
| Apr-03-20 | Initiated | Jefferies | Buy |
| Mar-12-20 | Initiated | Stifel | Buy |
| Feb-26-20 | Initiated | Piper Sandler | Overweight |
| Jan-30-20 | Initiated | Craig Hallum | Buy |
| Jun-14-19 | Upgrade | Ladenburg Thalmann | Neutral → Buy |
| Feb-08-19 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
View All
Avadel Pharmaceuticals Plc Stock (AVDL) Latest News
Analysts Are Updating Their Avadel Pharmaceuticals plc (NASDAQ:AVDL) Estimates After Its First-Quarter Results - Yahoo Finance
Needham & Company LLC Reaffirms “Buy” Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - Defense World
Avadel Pharma gains after appeals court ruling in Lumryz case with Jazz Pharma - MSN
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q1 2025 Earnings Call Transcript - Insider Monkey
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap Up Following Strong Earnings - Defense World
First Trust Advisors LP Grows Stock Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals Sees Strong Q1 Growth, Raises Guidance - TipRanks
Avadel: Q1 Earnings Snapshot - Midland Daily News
Transcript : Avadel Pharmaceuticals plc, Q1 2025 Earnings Call, May 07, 2025 - marketscreener.com
Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight - Yahoo Finance
AVADEL PHARMACEUTICALS PLC SEC 10-Q Report - TradingView
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance - The Manila Times
Avadel Pharma earnings beat, revenue fell short of estimates By Investing.com - Investing.com UK
Envestnet Asset Management Inc. Sells 32,618 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals (AVDL) Wins Court Victory for LUMRYZ Expa - GuruFocus
Avadel Pharmaceuticals (AVDL) Rises After Court Victory - GuruFocus
Federal Circuit Alters Avadel Pharmaceuticals (AVDL) Court Rulin - GuruFocus
Avadel Pharmaceuticals Wins Court Ruling for LUMRYZ Expansion - TipRanks
Avadel wins appeal to expand LUMRYZ trials beyond narcolepsy By Investing.com - Investing.com India
Avadel Pharmaceuticals Announces Favorable Ruling In Appeal Of Delaware Court Injunction - marketscreener.com
Avadel wins appeal to expand LUMRYZ trials beyond narcolepsy - Investing.com Australia
Avadel Pharmaceuticals (AVDL) Wins Court Victory for LUMRYZ Expansion | AVDL Stock News - GuruFocus
Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction - The Manila Times
Avadel Pharma seesaw after appeals court ruling in Lumryz case with Jazz Pharma (update) (AVDL:NASDAQ) - Seeking Alpha
Market Participants Recognise Avadel Pharmaceuticals plc's (NASDAQ:AVDL) Revenues Pushing Shares 28% Higher - simplywall.st
Invesco Ltd. Grows Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Investing in Avadel Pharmaceuticals plc (AVDL) might be a great opportunity, but the stock is a bit undervalued - uspostnews.com
Wells Fargo & Company MN Increases Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2025 Financial Results on May 7 - The Manila Times
Avadel Pharmaceuticals To Provide A Corporate Update - marketscreener.com
Trend Tracker for (AVDL) - news.stocktradersdaily.com
Avadel Pharmaceuticals plc (AVDL) rating initates by Deutsche Bank - knoxdaily.com
Top investors say Avadel Pharmaceuticals plc (AVDL) ticks everything they need - Sete News
UBS Adjusts Avadel Pharmaceuticals Price Target to $12 From $14, Maintains Buy Rating - marketscreener.com
LPL Financial LLC Purchases 10,072 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
JPMorgan Chase & Co. Has $1.17 Million Position in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
LPL Financial LLC Boosts Stock Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - The AM Reporter
Avadel Pharmaceuticals plc (AVDL)’s Market Momentum: Closing Strong at 8.60, Up 3.49 - DWinneX
Avadel Pharmaceuticals plc (AVDL)’s stock performance: a year in review - uspostnews.com
Press Release Distribution & PR Platform - ACCESS Newswire
AVDL Stock Sees Surge of Approximately 5.06% in Last Five Days - knoxdaily.com
Avadel Pharmaceuticals plc (AVDL) Performance and Fundamentals Dashboard tells a completely different story - Sete News
Geode Capital Management LLC Acquires 10,886 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Russell Investments Group Ltd. Acquires 11,350 Shares of Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Alliancebernstein L.P. Boosts Stake in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - Defense World
Insider Buying: Palczuk Linda, Avadel Pharmaceuticals plc [AVDL] Director invested 5,000 shares - knoxdaily.com
Avadel and nference Announce Publication of Real-World Data on Sodium Oxybate Treatment Patterns in the Journal of Clinical Neuroscience - TradingView
Equities Analysts Offer Predictions for AVDL Q1 Earnings - Defense World
Equities Analysts Set Expectations for AVDL Q2 Earnings - Defense World
Avadel Pharmaceuticals Plc Stock (AVDL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.82%
1.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):